Norihiro Nishimoto
- Rheumatology top 0.1%
- Rheumatoid Arthritis Research and Therapies 43
- Systemic Lupus Erythematosus Research 23
- Hematology top 0.2%
- Autoimmune and Inflammatory Disorders Research 29
- Immunology top 0.5%
- Immune Cell Function and Interaction 12
- Oncology top 0.5%
- Cytokine Signaling Pathways and Interactions 19
- Viral-associated cancers and disorders 12
- Genetics top 1%
-
- Monoclonal and Polyclonal Antibodies Research 17
-
- Lymphoma Diagnosis and Treatment 14
- Co-authors
- Tadamitsu KishimotoKazuyuki YoshizakiNobuhiro TakagiTetsuji NakaHideko NakaharaToru MimaJunichi AzumaTsutomu Takeuchi
- Cited by
- RheumatologyHematologyImmunology
- Journals
- Nature (1 paper)The Lancet (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Norihiro Nishimoto
128 papers receiving 10.7k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Rheumatology 3.6k
- Hematology 2.6k
- Immunology 3.9k
- Oncology 3.4k
- Genetics 674
Countries citing papers authored by Norihiro Nishimoto
This map shows the geographic impact of Norihiro Nishimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norihiro Nishimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norihiro Nishimoto more than expected).
Fields of papers citing papers by Norihiro Nishimoto
This network shows the impact of papers produced by Norihiro Nishimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norihiro Nishimoto. The network helps show where Norihiro Nishimoto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Norihiro Nishimoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 222 | |
| 2 | [IL-6 inhibitors prevent bone loss and cartilage degeneration in rheumatoid arthritis]. | 2015 | 11 |
| 3 | 2013 | 46 | |
| 4 | 2012 | 73 | |
| 5 | 2011 | 33 | |
| 6 | 2010 | 2 | |
| 7 | 2010 | 13 | |
| 8 | 2010 | 47 | |
| 9 | 2009 | 0 | |
| 10 | 2009 | 32 | |
| 11 | 2005 | 26 | |
| 12 | 2005 | 272 | |
| 13 | TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signalingbreakdown → | 2004 | 590 |
| 14 | 2003 | 323 | |
| 15 | 2002 | 112 | |
| 16 | 2000 | 47 | |
| 17 | 1998 | 0 | |
| 18 | 1997 | 3 | |
| 19 | 1991 | 1 | |
| 20 | 1990 | 72 |
About Norihiro Nishimoto
Norihiro Nishimoto is a scholar working on Rheumatology, Hematology and Immunology, having authored 132 papers that have together received 11.0k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (43 papers), Autoimmune and Inflammatory Disorders Research (29 papers), Systemic Lupus Erythematosus Research (23 papers), Cytokine Signaling Pathways and Interactions (19 papers), Monoclonal and Polyclonal Antibodies Research (17 papers), Lymphoma Diagnosis and Treatment (14 papers), Immune Cell Function and Interaction (12 papers) and Viral-associated cancers and disorders (12 papers). The work is most often cited by research in Rheumatology (3.6k citations), Hematology (2.6k citations) and Immunology (3.9k citations). Norihiro Nishimoto has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Tadamitsu Kishimoto, Kazuyuki Yoshizaki, Nobuhiro Takagi, Tetsuji Naka, Hideko Nakahara, Toru Mima, Junichi Azuma, Tsutomu Takeuchi, Nobuyuki Miyasaka and Kazuhiko Yamamoto. Their work appears in journals such as Nature, The Lancet and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.